Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Elevance Health Inc (NYSE: ELV) closed at $520.93 down -5.82% from its previous closing price of $553.14. In other words, the price has decreased by -$5.82 from its previous closing price. On the day, 3.87 million shares were traded. ELV stock price reached its highest trading level at $530.54 during the session, while it also had its lowest trading level at $509.0.
Ratios:
For a deeper understanding of Elevance Health Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.54.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on June 24, 2024, initiated with a Overweight rating and assigned the stock a target price of $643.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $649.
On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $584.Barclays initiated its Overweight rating on March 06, 2024, with a $584 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 24 ’24 when Norwood Felicia F sold 6,199 shares for $532.44 per share. The transaction valued at 3,300,590 led to the insider holds 27,304 shares of the business.
Norwood Felicia F sold 14,111 shares of ELV for $7,531,565 on Apr 23 ’24. The EVP & President,Gov Health Ben now owns 31,460 shares after completing the transaction at $533.74 per share. On Mar 08 ’24, another insider, Kendrick Charles Morgan JR, who serves as the EVP & President, Commercial of the company, sold 2,432 shares for $500.46 each. As a result, the insider received 1,217,119 and left with 15,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELV now has a Market Capitalization of 128559783936 and an Enterprise Value of 118845620224. As of this moment, Elevance’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.69, and their Forward P/E ratio for the next fiscal year is 12.51. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.70 while its Price-to-Book (P/B) ratio in mrq is 2.98. Its current Enterprise Value per Revenue stands at 0.692 whereas that against EBITDA is 10.657.
Stock Price History:
The Beta on a monthly basis for ELV is 0.84, which has changed by 0.09494281 over the last 52 weeks, in comparison to a change of 0.23228896 over the same period for the S&P500. Over the past 52 weeks, ELV has reached a high of $555.35, while it has fallen to a 52-week low of $431.38. The 50-Day Moving Average of the stock is -2.65%, while the 200-Day Moving Average is calculated to be 4.68%.
Shares Statistics:
For the past three months, ELV has traded an average of 1.01M shares per day and 1313486 over the past ten days. A total of 233.07M shares are outstanding, with a floating share count of 231.34M. Insiders hold about 0.46% of the company’s shares, while institutions hold 91.00% stake in the company. Shares short for ELV as of 1719532800 were 2191078 with a Short Ratio of 2.16, compared to 1717113600 on 1830004. Therefore, it implies a Short% of Shares Outstanding of 2191078 and a Short% of Float of 0.9400000000000001.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 1.14. The current Payout Ratio is 23.47% for ELV, which recently paid a dividend on 2024-06-10 with an ex-dividend date of 1717977600. Stock splits for the company last occurred on 2005-06-01 when the company split stock in a 2:1 ratio.
Earnings Estimates
Elevance Health Inc (ELV) is presently subject to a detailed evaluation by 20.0 analysts, each offering their unique perspectives on its market standing.On average, analysts expect EPS of $10.01 for the current quarter, with a high estimate of $10.27 and a low estimate of $9.82, while EPS last year was $9.04. The consensus estimate for the next quarter is $9.82, with high estimates of $10.51 and low estimates of $9.21.
Analysts are recommending an EPS of between $37.39 and $37.2 for the fiscal current year, implying an average EPS of $37.28. EPS for the following year is $41.65, with 23.0 analysts recommending between $42.3 and $40.11.
Revenue Estimates
For the next quarter, 14 analysts are estimating revenue of $43B. There is a high estimate of $43.62B for the next quarter, whereas the lowest estimate is $42.45B.
A total of 18 analysts have provided revenue estimates for ELV’s current fiscal year. The highest revenue estimate was $173.93B, while the lowest revenue estimate was $170.44B, resulting in an average revenue estimate of $172B. In the same quarter a year ago, actual revenue was $170.21BBased on 18 analysts’ estimates, the company’s revenue will be $183B in the next fiscal year. The high estimate is $187.68B and the low estimate is $178.56B.
